WHO has urged people at risk to keep up with their vaccinations with boosters. IMAGE: A healthcare worker administers a dose of iNCOVACC, an intranasal vaccine as a booster dose for a senior......
The Union health ministry on Thursday termed as 'misleading' and 'fallacious' media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.......
The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor......
The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Bharat Biotech Chairman and Managing Director Krishna Ella said on Wednesday, and also emphasised the......
Bharat Biotech is targeting one billion doses in annual production. This is from its own sites alone, reports Sohini Das. India’s first indigenous Covid-19 vaccine to be approved, Bharat......
The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results, reports Sohini Das. Photograph: Kind courtesy Bharat Biotech ......
While there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made......
Adjuvants may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed. Hyderabad based Bharat Biotech, whose Covid-19 vaccine......
The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred......
'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'Ritwik Sharma reports. IMAGE: A quality control test conducted at the Serum......